Skip to main content

Table 2 Changes in use of antiemetics and clinical characteristics associated with hyperemesis treatment guideline update (intervention) in 2014

From: Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019

 

Beta- coefficient

95% confidence interval

a) Antiemetics prior to hospitalization

Any antiemetic (%)

  Trend pre-intervention, β1

2.52

1.17; 3.87

  Level change at intervention, β2

-19.7

-33.8; -5.71

  Trend change post-intervention, β3

1.98

-0.67; 4.63

  Post-intervention trend, β1 + β3

4.50

1.99; 7.02

  p < 0.001

Metoclopramide (%)

  Trend pre-intervention, β1

2.22

1.29; 3.14

  Level change at intervention, β2

-30.2

-35.6; -24.8

  Trend change post-intervention, β3

2.65

0.26; 5.03

  Post-intervention trend, β1 + β3

4.86

2.68; 7.04

  p < 0.001

Prochlorperazine (%)

  Trend pre-intervention, β1

0.01

-0.47; 0.49

  Level change at intervention, β2

-0.86

-6.19; 4.47

  Trend change post-intervention, β3

2.05

0.35; 3.75

  Post-intervention trend, β1 + β3

2.06

0.48; 3.64

  p = 0.022

b) Antiemetics while at hospital

Beta- coefficient

95% confidence interval

Any antiemetic (%)

  Trend pre-intervention, β1

1.28

0.64; 1.91

  Level change at intervention, β2

-3.64

-9.64; 2.36

  Trend change post-intervention, β3

-1.69

-2.86; -0.52

  Post-intervention trend, β1 + β3

-0.42

-1.48; 0.65

  p = 0.002

Metoclopramide (%)

  Trend pre-intervention, β1

-2.88

-5.05; -0.70

  Level change at intervention, β2

-19.8

-36.7; -2.90

  Trend change post-intervention, β3

1.07

-1.48; 3.62

  Post-intervention trend, β1 + β3

-1.80

-2.97; -0.64

  p < 0.001

Prochlorperazine (%)

  Trend pre-intervention, β1

-0.16

-2.12; 1.80

  Level change at intervention, β2

40.5

18.2; 62.8

  Trend change post-intervention, β3

2.86

0.51; 5.21

  Post-intervention trend, β1 + β3

2.70

0.52; 4.88

p < 0.001

c) Clinical characteristics and outcomes

Beta- coefficient

98.75% confidence interval

Mean gestational age at first admission (days)

  Trend pre-intervention, β1

0.33

0.15; 0.49

  Level change at intervention, β2

-3.8

-7.1; -0.55

  Trend change post-intervention, β3

-0.24

-1.28; 0.80

  Post-intervention trend, β1 + β3

0.09

-0.93; 1.10

  p < 0.001

Mean weight change at first admission (% of pre-pregnancy weight)

  Trend pre-intervention, β1

-0.01

-0.09; 0.07

  Level change at intervention, β2

0.90

-0.23; 2.02

  Trend change post-intervention, β3

0.16

-0.14; 0.47

  Post-intervention trend, β1 + β3

0.15

-0.15; 0.45

  p = 0.0044

Admission rate (% of births)

  Trend pre-intervention, β1

-0.00

-0.03; 0.03

  Level change at intervention, β2

0.11

-0.27; 0.49

  Trend change post-intervention, β3

0.02

-0.10; 0.13

  Post-intervention trend, β1 + β3

0.02

-0.10;0.13

  p = 0.474

Rate of termination of pregnancy (% of admissions)

  Trend pre-intervention, β1

-0.05

-0.31; 0.21

  Level change at intervention, β2

4.81

0.86; 8.74

  Trend change post-intervention, β3

-0.75

-1.76; 0.25

  Post-intervention trend, β1 + β3

-0.81

-1. 77; -0.15

  p = 0.019

  1. One thousand sixty-four women admitted for treatment of HG at Haukeland University Hospital 2002–2019 presented as trend 2002–2013, level change associated with updated HG-guidelines in 2014, and trend change post-intervention. Interrupted time series-analysis with Newey-West standard errors adjusting for first order autocorrelation